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Abstract: Physiologically stable multimodality imaging probes for positron emission 
tomography/single-photon emission computed tomography (PET/SPECT)-magnetic resonance 
imaging (MRI) were synthesized using the superparamagnetic maghemite iron oxide (γ-Fe
2
O
3
) 
nanoparticles (SPIONs). The SPIONs were sterically stabilized with a finely tuned mixture of 
diblock copolymers with either methoxypolyethylene glycol (MPEG) or primary amine NH
2
 
end groups. The radioisotope for PET or SPECT imaging was incorporated with the SPIONs at 
high temperature. 57Co2+ ions with a long half-life of 270.9 days were used as a model for the 
radiotracer to study the kinetics of radiolabeling, characterization, and the stability of the radiola-
beled SPIONs. Radioactive 67Ga3+ and Cu2+-labeled SPIONs were also produced successfully using 
the optimized conditions from the 57Co2+-labeling process. No free radioisotopes were detected 
in the aqueous phase for the radiolabeled SPIONs 1 week after dispersion in phosphate-buffered 
saline (PBS). All labeled SPIONs were not only well dispersed and stable under physiological 
conditions but also noncytotoxic in vitro. The ability to design and produce physiologically stable 
radiolabeled magnetic nanoparticles with a finely controlled number of functionalizable end groups 
on the SPIONs enables the generation of a desirable and biologically compatible multimodality 
PET/SPECT-MRI agent on a single T2 contrast MRI probe.
Keywords: magnetic resonance imaging, positron emission tomography, single-photon emis-
sion computed tomography, SPIONs, radiolabeling
Introduction
Over the last two decades, nanotechnology has been extensively developed and applied 
in the field of imaging technology. Compared to the conventional use of single molecules 
as contrast agents for in vivo and in vitro imaging, nanoparticles and nanoparticulate 
assemblies offer significant advantages and are providing important contributions to the 
field of diagnostic and noninvasive molecular imaging. Due to their high surface area-
to-volume ratio, a higher amount of the desired payload can be incorporated with the 
contrast-generating nanoparticles/nanoparticulates, resulting in great improvements in the 
detection capability. Nanoparticles may allow imaging technologies to achieve a higher 
level of both anatomical and biological information with the use of a single probe.
The most popular dual-modality imaging technique in research involves a 
combination of UV/visible absorbance and/or fluorescence with magnetic resonance 
imaging (MRI). Nanoparticles with inherent optical properties, such as gold and 
quantum dots, have been labeled with a fluorophore or with an MRI contrast agent, 
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allowing their position to be pinpointed via MRI, while 
providing information on their environment via optical 
fluorescent signals.1–7 Despite the disadvantages of using a 
negative contrast agent (T2 weighted) in MRI, due to the 
low signal-to-noise ratio, significant advances over the last 
25 years have made the use of magnetic nanoparticles as 
T2 contrast agents preferable to the use of nanoparticles as 
T1-weighted contrast agents. Iron oxide magnetic nanoparti-
cles, due to their inherent magnetic properties and feasibility 
to produce iron oxide cores, are the most common negative 
(T2 weighted) contrast agents and have been widely applied 
to in vitro and in vivo studies.8–12 Among the dual-modality 
approaches, positron emission tomography/single-photon 
emission computed tomography (PET/SPECT)-MRI tech-
nologies offer high spatial resolution (~50 μm),13 the best 
soft tissue contrast, the highest sensitivity, and detection 
limit.14 The most common radionuclide probes applied as 
radiotracers or therapeutic agents in preclinical and clinical 
practice are 18F, 64Cu, 67Ga, 68Ga, 89Zr, 90Y, 124I, 99mTc, 111In, 
and 177Lu.12,15–18 These radionuclides have been incorporated 
into nanoparticles via coordination bonds with suitable func-
tional groups or chelating ligands on the nanoparticles.
Despite the fact that hybrid PET/SPECT-MRI technologies 
have been emerging as new tools utilizing molecular probes 
for in vivo biomolecular and cellular imaging, as well as (pre-)
clinical imaging in medical theranostics (a combination of 
therapy and diagnostics), a number of challenges in the pro-
duction and performance of suitable and safe multimodality 
probes remain. The first challenge is the manufacture of imag-
ing probes for clinical application. Robust synthesis, unifor-
mity, batch-to-batch reproducibility, scaling-up, and colloidal 
stability remain aspects to be developed and optimized.19 The 
second and most concerning challenge is probe biosafety, in 
particular their side effects when used in vivo and in clini-
cal applications. Recently, systemic fibrosis was detected in 
clinical patients who had previously undergone administra-
tion of imaging contrast agents for MRI scans.9,20,21 This side 
effect is suggested to be associated with the loss of toxic 
metal ions from the contrast agents.20 In March 2015, the US 
Food and Drug Administration issued a report warning about 
the application of Feraheme (AMAG Pharmaceuticals, 
Lexington, MA, USA), an iron oxide-based product, in the 
treatment of anemia due to a number of reported serious side 
effects in patients.22 These challenges are likely the reason 
why nanoparticle platforms remain limited to preclinical use, 
despite their potential applications in theranostics.23
Our previous studies showed that the sterically stabilized 
superparamagnetic iron oxide nanoparticles (s-SPIONs) were 
stable under physiological conditions, noncytotoxic in vitro, 
and have shown potential biomedical applications in drug 
delivery and stem cell tracking.11,24 Our recent publication 
further demonstrated that these sterically stabilized SPIONs 
were highly stable and well dispersed after being mixed with 
fresh human red blood cells.25 This work presents a robust 
aqueous-based production of multimodality PET/SPECT-
MRI probes on single core superparamagnetic iron oxide 
(maghemite γ-Fe
2
O
3
) nanoparticles (SPIONs). Two types 
of sterically stabilized SPIONs are used in this study: 10 nm 
diameter (small core) and 25 nm diameter (big core) SPIONs 
with T2 relaxivity values of 368 s-1mM-1 and 953 s-1mM-1, 
respectively.10,11 This potentially offers better negative 
MRI contrast agents than all commercially and clinically 
available samples of similar core sizes. Ligand-free radio-
labeling, which was developed recently for commercially 
available iron oxide nanoparticles with PET radiotracers,26,27 
is applied to incorporate metal ions of Co, Ga, and Cu as 
models for PET/SPECT radiotracers. Radiolabeling kinet-
ics, stability, and cytotoxicity of the radiolabeled SPIONs 
are also investigated.
Materials and methods
Materials
Two different core sizes of the maghemite iron oxide 
(γ-Fe
2
O
3
) with average diameter of 10 nm (SPION10) and 
25 nm (SPION25) were used in this study. The SPIONs 
were sterically stabilized with a mixture of 5% NH
2
 and 
95% methoxypolyethylene glycol (MPEG, molar ratio) 
end functionalized macro-reversible addition fragmenta-
tion chain transfer (RAFT) blocks as reported in our previ-
ous publication11,24 and referred to herein as s-SPION10 
and s-SPION25. All the SPION samples, both uncoated 
and coated particles, were diluted with Milli-Q water to a 
concentration of 1 wt% prior to radiolabeling.
Cobalt(II) nitrate hexahydrate (Co(NO
3
)
2
⋅6H
2
O, 
99.999% trace metals basis), gallium(III) chloride (GaCl
3
, 
99.999% trace metals basis), copper(II) nitrate trihydrate 
(Cu(NO
3
)
2
⋅3H
2
O, .99%), and hydrochloric acid (HCl, 
30%–35%, TraceSELECT® Ultra) were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Milli-Q water was 
used throughout this work. Cell culture media were pur-
chased from Thermo Fisher Scientific (Waltham, MA, 
USA). All cell lines used in the in vitro tests were from 
ATCC (Manassas, VA, USA). Cobalt-57 chloride (57CoCl
2
) 
in 0.02 M hydrochloric acid was purchased from Perkin 
Elmer (Waltham, MA, USA). Gallium-67 chloride (67GaCl
3
) 
in 0.1 M hydrochloric acid suitable for radiochemistry was 
produced from gallium-67 citrate for injection (Lantheus 
Medical Imaging, Billerica, MA, USA) using established 
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procedures.28 Copper-64 chloride (64CuCl
2
) in 0.02 M HCl 
was obtained from RAPID Labs, SCGH (Perth, Australia).
experimental methods
labeling the sterically stabilized sPIONs with co2+, 
ga3+, and cu2+
Scheme 1 shows the chemical structures and schematic 
pictures of the stabilized SPIONs. All of the SPION samples, 
both uncoated and coated particles, were diluted with Milli-Q 
water to a concentration of 1 wt% prior to labeling.
Reactions of SPIONs (1 wt%, 50 μL) with Co(II) nitrate, 
Ga(III) chloride, or Cu(II) nitrate (1 mM in 0.1 M HCl, 40 μL) 
were carried out at different pH values and temperatures. 
Sodium acetate buffers (pH 4, 4.5, 5, 5.5, and 1.0 M) and 
sodium acetate (1.0 M) were added to the reaction mixtures 
to the final concentrations of 0.1 M. The reaction mixtures 
(400 μL) were then heated at either 75°C or 95°C using an oil 
bath for 30 min, after which the free metal ions were separated 
from the SPIONs by centrifuging at 10,000 rpm for 30 min. 
After removing supernatant, the SPIONs were washed twice 
with Milli-Q water and then redispersed in 400 μL Milli-Q 
water. Metal concentrations in the reaction mixtures, superna-
tants, and products were analyzed by graphite furnace atomic 
absorption spectroscopy (GF-AAS).
radiolabeling of sPIONs with 57co and 67ga
Preparation of [57Co/natural (nat)Co]2+ radiotracer stock 
solution
Serial solutions of Co(NO
3
)
2
 (0.10, 1.0, and 10 mM in 0.1 M 
HCl) were prepared by diluting 0.1 M Co(NO
3
)
2
 stock (2.91 g 
Co(NO
3
)
2
⋅6H
2
O in 10 mL of 0.1 M HCl) in 0.1 M HCl. An 
aliquot of 57Co in 0.1 M HCl (~7 MBq) was mixed with the 
stock solutions of Co(NO
3
)
2
 (0.1 or 1 mM) to give a final 
activity of ~300 kBq per reaction prior to the radiolabeling.
radiolabeling of sPIONs
Each radiolabeling experimental condition was carried 
out in triplicate to establish the reproducibility of the 
applied process.
Radiolabeling of SPIONs with [57Co/natCo]2+ (~1 kBq/nmol) 
was carried out in sodium acetate buffer (final concentration 
of 0.1 M). Typically, an aliquot of 1.0 M sodium acetate 
(40 μL) was added into an acid-washed 1.5 mL micro-
centrifuge tube, followed by the addition of Milli-Q water 
(300 μL), [57Co/natCo]2+ tracer solution, and 1 wt% SPION 
suspension (50 μL, 0.5 mg of Fe). The reaction mixture 
was placed on a heating block at a targeted temperature for 
30 min. After cooling for 10 min, 20 μL of reaction mixture 
was aliquoted from the reaction mixture, and the radioactivity 
was measured using a gamma counter. The remaining por-
tion was centrifuged at 10,000× g for 20 min. Then, 20 μL 
of the supernatant, containing unreacted [57Co/natCo]2+, was 
aspirated out to measure the radioactivity; the remaining 
supernatant was discarded. The radiolabeled SPIONs were 
redispersed in Milli-Q water using a sonic bath for 10 min. 
The control samples were prepared, in which the volume 
of SPIONs was replaced by Milli-Q water. The radiola-
beling efficiencies were calculated as the percentages of 
(total radioactivity − radioactivity of supernatant)/total 
radioactivity.
Scheme 1 schematic composition of the sterically stabilized sPIONs and the radiolabeled products.
Notes: The steric stabilizers for sPIONs contained anchoring phosphate blocks (red) to iron oxide core surface and stabilizing blocks of 95% (by molar ratio) MPeg (blue) 
and 5% Nh2 end functionalized polyacrylamide (green) (x=6; y=0 and 40 for small and big cores, respectively; m=20 and 60 for small and big cores, respectively).
Abbreviations: sPIONs, superparamagnetic iron oxide nanoparticles; MPeg, methoxypolyethylene glycol; PeT, positron emission tomography; sPecT, single-photon 
emission computed tomography; MrI, magnetic resonance imaging.
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A similar procedure was also applied for the labeling 
of SPIONs with 67Ga3+ and (nonradioactive) Cu2+ unless 
stated otherwise.
stability studies in physiological media
Radiolabeled SPIONs were redispersed in different media, 
including 0.9% saline, phosphate-buffered saline (PBS), 
or 5% glucose solution, by sonication for 10 min to check 
their dispersity. The dispersions were maintained at room 
temperature for up to 7 days to check their stability. At various 
time intervals, the dispersions were centrifuged at 10,000 rpm 
for 20 min. Then, 20 μL of the dispersion (before centrifuga-
tion) and of the supernatant (after centrifugation) were col-
lected to measure radioactivity on the gamma counter. The 
particles pellet was redispersed in the media via sonication.
characterization methods
Dynamic light scattering (Dls) and transmission 
electron microscopy (TeM)
A DLS instrument (Zetasizer nanoseries, helium–neon laser at 
633 nm, 40 mW; Malvern Instruments, Malvern, UK) with a 
detection angle of 173° was used to measure the particle sizes. 
Samples were measured at 25°C. The particles were dispersed 
in Milli-Q water or PBS at 0.5 mg/mL prior to measurement.
TEM analysis was performed in a JEOL 1400 at an accel-
erating voltage of 200 kV. A diluted sample (about 10 μg/mL 
in water) of SPIONs was drop casted onto a 200 meshed 
carbon-coated Formvar™ copper TEM grid and air-dried 
before imaging.
atomic absorption spectroscopy (aas) to measure 
metal contents in sPIONs
The iron content in the SPIONs was measured using an AAS 
instrument (Varian AA800 spectrometer, with acetylene/air 
flame atomization). An iron standard solution (1,000 mg/L 
in HNO
3
; Merck, Darmstadt, Germany) was used for the 
calibration curve. Samples of dried SPIONs were digested 
in nitric acid (trace analysis grade, EM-1.00441.1000, 65% 
[w/v]; Millipore, Billerica, MA, USA), followed by a dilution 
with 0.1 M HCl (Merck) prior to the measurement.
Concentrations of cobalt, gallium, and copper were analyzed 
using a GF-AAS (Agilent 240FS AA spectrometer with a Zee-
man graphite tube atomizer). The standard solutions of Co(II), 
Ga(III), and Cu(II) at 25, 50, and 40 ppb, respectively, in 0.1 M 
HCl were used for the calibration curve of each element.
gamma counter to measure radioactivity of the 
radiolabeled sPIONs
The radiolabeling efficiency for SPIONs labeled with 57Co 
or 67Ga, under different conditions, was determined by 
gamma counting of the particles and supernatant solutions 
using a Gamma Counter (Wizard 2480; Perkin Elmer). 
The particles suspension in an Eppendorf tube was centri-
fuged at 14,000× g for 20 min to obtain clear supernatant. 
Then, 10 μL of the particle suspension or the supernatant 
from each SPION sample, in triplicate, was placed in a 
glass culture tube (6×50 mm), and the radioactivity was 
measured on a gamma counter (300 s count time for each 
measurement).
cell culture and viability assay
3T3-L1 and L6 cells (kind gifts from Dr Aviva Levina) were 
maintained as confluent monolayers in Dulbecco’s Modified 
Eagle’s Medium (DMEM, 10566-016; Gibco, Grand Island, 
NY, USA), supplemented with 10% (v/v) fetal calf serum 
(FCS). The cells were incubated under standard culturing 
conditions (at 37°C with 5% [v/v] CO
2
 under humidified 
conditions). Cells were routinely subcultured by removal of 
the medium, washing with PBS (IVT3001302; In Vitro Tech-
nologies, Noble Park North, VIC, Australia), and detached 
from the culture-ware by 0.25% (w/v) trypsin (59430C; 
SAFC Biosciences, Brooklyn, VIC, Australia). The cell sus-
pension was collected in a centrifuge tube with the addition 
of complete growth medium and spun down at ~1,000 rpm 
for 3 min. The supernatant was discarded, and the cells 
were resuspended in fresh growth medium. Cells were then 
counted on a hemocytometer, and an appropriate number of 
cells were seeded for further experiments and subculturing.
A total of 1×105 cells/well suspension was seeded into 
each well of a 96-well plate (3599; Corning, Kennebunk, 
ME, USA) and incubated for 24 h under standard culturing 
conditions. Prior to the assay, SPION suspensions, including 
Cu-s-SPION10, Cu-s-SPION25, Ga-s-SPION10, and Ga-
s-SPION25, were sterilized by filtration with a hydrophilic 
regenerated cellulose 0.22 μm filter. The dose volume of the 
nanoparticles was kept ,24% of the total volume. A sample 
of the filtered particles in cell media at a desired concentra-
tion was processed for AAS to confirm the concentration 
of SPIONs applied to cells. The filtered particles were 
diluted in complete culture medium and added to triplicate 
wells spanning a 3-log range of final concentrations (250, 
125, 62.5, 31.2, 15.6, 7.81, and 3.91 ppm, unless otherwise 
stated). The cells were then incubated for 24 or 72 h before 
1.0 mM thiazolyl blue tetrazolium bromide (MTT; L11939; 
Alfa Aesar, Heysham, UK) was added and further incubated 
for 4 h. The media was removed, and 200 μL of dimethyl 
sulfoxide (DMSO; Sigma-Aldrich) was added to each well. 
The absorbance at 600 nm was then measured for the plate 
in a Victor3V microplate reader (1420; Perkin Elmer). IC
50
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values were determined as the drug concentration that reduced 
the absorbance to 50% of that in untreated control wells.
Results and discussion
Quantitative measurements of co2+ 
concentration on sPIONs
radiolabeling of sPIONs with [57Co/natCo]2+: effect 
of ph and temperature
Initially we investigated suitable and optimum conditions 
for radiolabeling. The first parameter we investigated was 
pH. Inorganic bases are often used to adjust the pH for 
radiolabeling reactions by many research groups.26,27 Then, 
0.1 M NaOH was first used to adjust the pH of the reaction 
mixture to 8.0. However, the use of NaOH resulted in the 
pH becoming excessively high and causing precipitation of 
Co(OH)
2
 in the reaction mixture. As shown in Figure 1A, 
in the control sample without the presence of SPIONs, an 
extremely low level of activity (10% of the total) was detected 
in the supernatant after centrifugation when using NaOH to 
adjust the pH, whereas when using 0.1 M sodium acetate 
directly to obtain pH 8, ~100% of the total activity remained 
in the supernatant after centrifugation.
The radiometal labeling was also influenced by the pH 
of the reaction mixture. When using sodium acetate buffer, 
increasing pH (from 4.0 to ~8.0), at the same reaction tempera-
ture of 95°C, resulted in a marked improvement in radiochemi-
cal yield for the radiolabeling of SPIONs with [57Co/natCo]2+. 
Experimental data shown in Figure 1B illustrate that under low 
pH conditions (acetate buffer, pH =4.0–5.5), low radiochemi-
cal yields, ,20%, were obtained for s-SPION10. The highest 
radiolabeling efficiency (~77%) was obtained when the reac-
tion was carried out using 0.1 M sodium acetate at pH ~8. A 
range of temperatures were also studied to find out an optimum 
reaction temperature for the labeling reaction. Results shown 
in Figure 1C illustrate that under the pH 8.0 acetate buffer 
as the optimum buffer, increasing temperature also signifi-
cantly improved radiochemical yield for both s-SPION10 and 
s-SPION25. At room temperature (25°C), the radiochemical 
yield with [57Co/natCo]2+ only reached 26% and 10% for 
s-SPION10 and s-SPION25, respectively. When heating the 
reaction mixtures to 75°C for 30 min, the radiochemical yield 
was ~75% and 40% yield for s-SPION10 and s-SPION25, 
respectively. The highest radiochemical yields, ~75% and 
57% for s-SPION10 and s-SPION25, respectively, were 
Figure 1 radiolabeling sPIONs with radioactive cobalt.
Notes: Dispersion of sPIONs (1 wt%, 50 μl, s-sPION10 or s-sPION25) was added into a solution of [57Co/natCo]2+ (~10 KBq, [natco2+] =2 nmol) in (A) 0.1 M sodium 
acetate (ph ~8) or water with ph adjusted to 8 using 0.1 M NaOh, heated at 95°c for 30 min; (B) 0.1 M acetate buffer at different ph (4–8), heated at 95°c for 30 min; 
(C) 0.1 M sodium acetate (ph ~8), heated at different temperatures of 25, 75, or 95°c for 30 min; and (D) 0.1 M sodium acetate (ph ~8), heated to 95°c for 30 min. error 
bars = standard errors, n=3.
Abbreviations: nat, natural; DOTa-sPIONs, s-sPIONs with DOTa (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) as chelating ligand conjugated to the Nh2 
end group of the stabilizer; sPIONs, superparamagnetic iron oxide nanoparticles; s-sPIONs, stabilized sPIONs; s-sPION10, s-sPIONs with average core diameter of 10 nm; 
s-sPION25, s-sPIONs with average core diameter of 25 nm.
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obtained when the reaction mixtures were heated at 95°C for 
30 min. As the same amount of iron oxide mass was used in all 
cases, the number of particles, ie, the number of reaction sites, 
for the smaller size particles was significantly higher than that 
for the bigger ones. This resulted in the higher radiochemical 
yield for s-SPION10 under the same conditions. From these 
results, a temperature of 95°C and 0.1 M sodium acetate, 
pH 8.0, were chosen for the radiolabeling of SPIONs with 
[57Co/natCo]2+ for further studies.
As the SPIONs were coated with polymer blocks that 
could potentially chelate to metal ions, it is important 
to determine whether the [57Co/natCo]2+ ions bind to the 
nanoparticle surface or the polymer-coating layers. The 
uncoated SPIONs, the coated SPIONs as well as the 
coated SPIONs with 1,4,7,10-tetraazacyclododecane-1,4,7, 
10-tetraacetic acid as chelating ligand conjugated to the 
NH
2
 end group of the stabilizer (DOTA-SPIONs) were 
labeled with [57Co/natCo]2+ using the same conditions; 
0.1 M sodium acetate, at 95°C for 30 min. The radioactiv-
ity obtained on the nanoparticles (Figure 1D) was similar 
between three particle types, ~3.3 and 2.5 nmol of Co2+/mg 
of 10 and 25 nm SPIONs, respectively. This result strongly 
indicates that Co2+ ions are likely deposited on the surface 
of the iron oxide core, even in the presence of additional 
chelating ligands.
loading capacity of [57Co/natCo]2+ on s-sPIONs
To further investigate the metal binding capacity of Co2+ on the 
s-SPIONs, fixed amounts of s-SPIONs (0.5 mg) were added 
into reaction mixtures with increasing ratios of natCo2+/57Co2+ 
(Figure 2). To minimize the use of higher radioactivity level, 
we did not aim to extend the duration of a radiolabeling reac-
tion. Thus, we chose a reaction time of 30 min and evaluated 
the optimum concentration and conditions to achieve a highest 
possible radiolabeling yield. The fixed amount of 57Co2+ would 
act as a radiotracer for the experiment. Once the loading limit 
of natCo2+ loading was reached, increasing levels of 57Co2+ 
would be found in the supernatant. The reaction conditions 
were maintained constant; 95°C for 30 min; the amount of 
[57Co/natCo]2+ led to an elevated level of [57Co/natCo]2+ in the 
product (Figure 2A). As expected, the radiochemical yield 
decreased with increasing ratios of natCo2+ to 57Co2+ (Figure 2B). 
Using 400 nmol of natCo2+/mg of s-SPIONs gave ~170 nmol 
(yield 42%) and 110 nmol (yield 28%) [57Co/natCo]2+/mg of 
s-SPION10 and s-SPION25, respectively. Meanwhile, the 
radiochemical yields reached 90% for s-SPION10 and 71% for 
s-SPION25 within 30 min of reaction time when only 2 nmol 
of [57Co/natCo]2+/mg of s-SPIONs were used.
stability of [57Co/natCo]2 labeled-sPIONs 
([57Co/natCo]2+-s-sPIONs) in simulated 
physiological conditions
As anticipated, the experimental data showed that the radio-
labeled nonstabilized SPIONs were not dispersible at all 
in aqueous phases. The particles coagulated and/or aggre-
gated and settled down to the bottom of the vial rapidly. Any 
aggregation or flocculation of particles under physiological 
conditions would cause the blocking of blood vessels or local 
retention of particles upon treatment and therefore result in 
an acute toxicity of the particles.
Figure 2 loading capacity of co2+ on s-sPIONs after the reaction for 30 min at 95°c in 0.1 M sodium acetate.
Notes: (A) amounts of co2+ loaded on s-sPIONs (nmol/mg of dry s-sPIONs) and (B) labeling yield (%) when increasing the amounts of 57co/co2+ added in the reaction 
mixtures. error bars = standard errors, n=3.
Abbreviations: sPIONs, superparamagnetic iron oxide nanoparticles; s-sPIONs, stabilized sPIONs; s-sPION10, s-sPIONs with average core diameter of 10 nm; s-sPION25, 
s-sPIONs with average core diameter of 25 nm.
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On the other hand, due to the coating layer of steric 
stabilizers, radiolabeling the s-SPIONs did not alter the 
aqueous-phase dispersability of the initial s-SPIONs. Dur-
ing the radiolabeling, the s-SPIONs remained well dis-
persed under the harsh reaction conditions, including high 
concentration of buffer and high temperature (Figure 3A). 
Radiolabeled s-SPIONs could be easily resuspended and 
were stable in various aqueous dispersing media, including 
water, 0.9% saline, and PBS. The AAS results for the filtered 
s-SPIONs and labeled s-SPIONs (data not shown) showed 
that the concentration of iron given by SPIONs did not change 
after being filtered through a sterile 0.22 μm filter (to sterile 
SPIONs for in vitro cytotoxicity tests), which is another solid 
evidence of the well dispersed and stable s-SPIONs.
Retention of the radionuclide with the vector is a critical 
aspect of radiotracer development. Loss of the radionuclide 
may result in localization in untargeted tissue or untimely 
excretion, thus it is important that the radionuclides remain 
bound to the particles. We investigated this property of 
our particles by incubation of [57Co/natCo]2+-s-SPIONs in 
water, saline, and PBS for 24 h. We observed that ,2% 
of the total activity was leached out from the cores during 
this time period, indicating very stable binding of the 
radiometal (Figure 3B).
labeling s-sPIONs with PeT/sPecT agents
With the optimization of radiolabeling conditions and the 
excellent stability of 57Co-s-SPIONs, we investigated the 
radioisotopes potentially useful as SPECT and PET imaging 
agents, 67Ga and 64Cu, respectively.
s-sPIONs labeled with 67ga
Similar conditions were applied to investigate the reac-
tion between s-SPIONs and 67Ga. In this study, a mixture 
of [67Ga/natGa]3+ was prepared by adding 10 μL of 67Ga 
(~2.5 MBq, chloride form in 0.1 M HCl) to 200 μL of 
0.1 mM Ga(III) nitrate solution in 0.1 M HCl. The reaction 
was carried out at either pH 5.5 (0.1 M acetate buffer) or 
pH 8 (0.1 M sodium acetate) and heated at 95°C for 30 min. 
The radiochemical yield was found to be almost quantitative 
(100%) at both pHs and for both s-SPION10 and s-SPION25 
(Figure 4A).
studying the reactions of s-sPIONs with 
nonradioactive cu2+ and ga3+ and the 
stability of the products
The high labeling efficiency of s-SPIONs with 57Co and 67Ga 
and the stability of the products have been demonstrated. 
These studies were repeated using nonradioactive cations, 
including Cu2+ and Ga3+. Furthermore, the colloidal proper-
ties of the s-SPIONs, including particle size and stability, 
and the toxicity of the labeled s-SPIONs were also studied. 
The amount of metal cations was quantified by GF-AAS. The 
reactions with Cu2+ or Ga3+ at different pHs and temperatures 
were only performed with s-SPION25 (Figure 4B and C). The 
control reactions, in which no s-SPION25 was added, were 
carried out simultaneously to monitor for the precipitation of 
metal oxide or hydroxide in the higher pH buffers. Under all 
studied conditions, 100% of added metal cations were found 
to remain in the supernatant after centrifugation (data not 
shown). Similar to what we observed in radioactive labeling 
Figure 3 colloidal and radiochemical stability of sPIONs.
Notes: (A) Well dispersion of the stabilized sPIONs in water and PBs after labeling with 57co (bottom) in contrast to the unstabilized sPIONs (top) and (B) the activity of 
57co remained on [57Co/natCo]2+-s-sPIONs after 24 h under physiological conditions. error bars = standard errors, n=3.
Abbreviations: nat, natural; sPIONs, superparamagnetic iron oxide nanoparticles; s-sPIONs, stabilized sPIONs; s-sPION10, s-sPIONs with average core diameter of 
10 nm; s-sPION25, s-sPIONs with average core diameter of 25 nm; NP, nanoparticle; PBs, phosphate-buffered saline.
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with 67Ga, the reaction of Ga3+ with s-SPION25 was less pH 
and temperature dependent. The reaction yields after heating 
to 95°C at pH 5 and 8 were ~93% and ~99%, respectively 
(Figure 4B). The yield obtained at pH 3.6 was slightly lower 
(~80%). Using 0.1 M sodium acetate (pH ~8), ~100% of 
Ga3+ added in the reaction mixture bound to s-SPION25 not 
only at 95°C but also at 25°C, 60°C, and 75°C (Figure 4C). 
In contrast, the reaction of s-SPION25 with Cu2+ was strongly 
pH and temperature dependent as shown in Figure 4B and C. 
The labeling process required high temperature and high pH 
????????????
?????????
????????????????
????
?
? ?? ??? ????? ??????????????????? ? ?? ??? ????? ??????
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Figure 4 labeling s-sPIONs with ga and/or cu.
Notes: (A) Labeling efficiency of s-SPIONs (1 wt%, 50 μl, s-sPION10 or s-sPION25) with [67Ga/natGa]3+ (~125 KBq, 1 nmol ga3+) at ph 5.5 (0.1 M acetate buffer) or at ph 
8 (0.1 M sodium acetate), heating at 95°c for 30 min. (B and C) Labeling efficiency of s-SPION25 with Cu2+ and ga3+ (in 0.1 M sodium acetate at different phs, heating at 
95°c for 30 min, and at different temperatures, ph 8, for 30 min). constant amounts of 0.5 mg s-sPIONs and 1 nmol of metal ions were used in all reactions. (D) stability 
of Cu-s-sPION25 and Ga-s-sPION25 after 24 h incubation in different media represented by the percentages of cu or ga remained bound to nanoparticles. (E) co-labeling 
of s-sPIONs with cu2+ and ga2+ at 95°c after 30 min resulted in ~100% yield for both metal cations. (F) Dls of s-sPIONs before and after labeling with ga3+ or cu2+ did not 
show any changes in the hydrodynamic size. (G) Transmission electron micrographs of the sterically stabilized particles before labeling (s-sPION10 and s-sPION25) and after 
labeling with cu2+ (Cu-s-sPION10 and Cu-s-sPION25) or with ga3+ (Ga-s-sPION10 and Ga-s-sPION25); scale bars: 50 nm. error bars = standard errors, n=3.
Abbreviations: cu-s-sPION10, s-sPIONs with average core diameter of 10 nm and labeled with cu; ga-s-sPION10, s-sPIONs with average core diameter of 10 nm and 
labeled with ga; cu-s-sPION25, s-sPIONs with average core diameter of 25 nm and labeled with cu; ga-s-sPION25, s-sPIONs with average core diameter of 25 nm and 
labeled with ga; sPIONs, superparamagnetic iron oxide nanoparticles; s-sPIONs, stabilized sPIONs; s-sPION10, s-sPIONs with average core diameter of 10 nm; s-sPION25, 
s-sPIONs with average core diameter of 25 nm; PBs, phosphate-buffered saline; Fcs, fetal calf serum; Dls, dynamic light scattering.
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in order to obtain a high yield of the product. Specifically, in 
0.1 M sodium acetate and heating at 95°C for 30 min, ~90% 
of added Cu2+ was deposited on the surface of s-SPION25.
The Cu-s-SPION25 and Ga-s-SPION25 were incubated 
for 24 h in various media including water, 0.9% saline, PBS, 
and 10% FCS to study the dissociation of Cu and Ga from 
SPIONs into the media. All samples remained dispersed in 
these media. GF-AAS analyses of Cu and Ga concentrations 
in the supernatant after centrifugation showed that ,1% of 
both Cu and Ga were released from SPIONs in either water 
or saline (Figure 4D). Incubation of labeled s-SPIONs in 
PBS or FCS resulted in ,10% of Ga and Cu leaching. 
However, this could be due to the presence of s-SPIONs 
still remaining in the supernatant after centrifugation as the 
errors were significant.
In addition, using this method, labeling s-SPIONs with 
both Cu2+ and Ga3+ for hybrid PET-SPECT imaging was 
successfully carried out. The multiradioisotope-labeled 
s-SPIONs offer high potential as all-in-one PET/SPECT-MRI 
agents. Applying reaction conditions that gave the highest 
efficacy for both Cu2+ and Ga3+, 0.1 M sodium acetate and 
heating at 95°C for 30 min, using equal amounts of Cu2+ 
and Ga3+ (1 nmol) for the reaction with either s-SPION10 
or s-SPION25 (0.5 mg), ~100% yield and .90% yield were 
achieved for Ga3+ and Cu2+, respectively (Figure 4E).
The hydrodynamic size of the labeled s-SPIONs did 
not change after going through a tough preparation process 
involving high salt concentration, high temperature, and high-
speed centrifugation (Figure 4F). The TEM images of the 
SPIONs before and after metal labeling (Figure 4G) showed 
that the labeling processes did not change the core size or 
the appearance of the particles significantly. The observed 
excellent stability properties of these s-SPIONs are crucial for 
nanomedicine applications as they should ensure their stabil-
ity during preparation and future investigations in vivo.
It is worth noting that all (radio-)metal-labeling processes 
described above were robust and reproducible with very small 
standard errors (Figures 1–4).
Toxicity of the metal-labeled s-sPIONs 
in vitro
The toxicity of the s-SPION10 and s-SPION25 in various 
cell lines was described in our previous reports.10,11,24 In 
order to study the safety of the labeled s-SPIONs by MTT 
assay, four samples of Cu-s-SPION10, Cu-s-SPION25, Ga-s-
SPION10, and Ga-s-SPION25 were prepared in larger scale 
using 10 mg of s-SPION10 or s-SPION25 and 0.6 μmol of 
Cu2+ or Ga3+. The reactions were carried out in 0.1 M acetate 
buffer (pH 8.0) at 95°C for 30 min, and then the labeled 
products were collected by centrifugation and washed three 
times with water prior to redispersing in 1 mL of water. 
The concentrations of Fe and Cu or Ga in the final products 
were quantified by GF-AAS. For the MTT assay, all four 
samples were diluted with saline to the final concentrations 
of 50 mM Fe, and concentrations of Cu and Ga are given in 
Table 1. The highest concentration of the labeled s-SPIONs 
tested on two cell lines was 3.0 mM of Fe (corresponding 
to 250 μg/mL Fe
2
O
3
). No cytotoxicity was observed on 
L6 muscle cells and 3T3-L1 preadipocytes at the highest 
concentration tested as shown in Figure 5.
The good dispersity, stability in aqueous media, and 
noncytotoxicity of the sterically stabilized SPIONs, both 
before10 and after labeling with radiometal and metal ions (as 
shown in this study), are essential requirements for imaging 
contrast agents in particular and for any further biomedical 
application in general.
Conclusion
SPIONs with excellent MRI-negative contrast were suc-
cessfully radiolabeled with the SPECT radioisotope, 67Ga, 
or with the PET radioisotope, 64Cu, in acetate buffer. The 
radiochemical yields of radiolabeling with 57Co were found 
to be strongly dependent on temperature and time for both 
raw ferro-fluid (unstabilized iron oxide cores) and sterically 
stabilized SPIONs. No detectable loss of radionuclides from 
the particles to the aqueous phase in various physiological 
media was observed. The sterically stabilized radiolabeled 
s-SPIONs were fully redispersed and remained stable in 
aqueous buffer solutions such as PBS (Figure 5) and were 
also shown to be noncytotoxic in vitro. These are crucial 
properties of nanoparticles for an injectable formulation in 
biomedical applications.
In addition to the synthesis of the well-defined PET/SPECT-
MRI, our capability to synthesize SPIONs with heteroge-
neous coating, which consists of different end functional 
groups such as –NH
2
 on the stabilizing molecules,11,24 also 
Table 1 concentrations of labeled s-sPIONs used in MTT assay 
for cell viability
Sample [Fe] (mM) [Cu] or [Ga] (µM)
cu-s-sPION10 50 273
ga-s-sPION10 50 282
cu-s-sPION25 50 234
ga-s-sPION25 50 241
Abbreviations: [cu], copper concentration; [Fe], iron concentration; [ga], 
ga concentration; MTT, thiazolyl blue tetrazolium bromide; cu-s-sPION10, 
s-sPIONs with average core diameter of 10 nm and labeled with cu; ga-s-sPION10, 
s-sPIONs with average core diameter of 10 nm and labeled with ga; cu-s-sPION25, 
s-sPIONs with average core diameter of 25 nm and labeled with cu; ga-s-sPION25, 
s-sPIONs with average core diameter of 25 nm and labeled with ga; s-sPIONs, 
stabilized superparamagnetic iron oxide nanoparticles.
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enable us to carry out further postmodification with finely 
controlled amounts of an appropriate targeting agent and/or 
fluorescent imaging agent.
This study offers a robust and simple production for a 
potential next generation of nontoxic multimodality PET/
SPECT-MRI single probe imaging agents.
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